These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Aldosterone and its antagonists in heart failure]. Lopes ME; Le Corvoisier P; Tabet JY; Su JB; Badoual T; Cachin JC; Merlet P; Castaigne A; Hittinger L Presse Med; 2003 Jan; 32(2):79-87. PubMed ID: 12653034 [TBL] [Abstract][Full Text] [Related]
47. Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF). Capuano A; Scavone C; Vitale C; Sportiello L; Rossi F; Rosano GM; Coats AJ Int J Cardiol; 2015 Dec; 200():15-9. PubMed ID: 26404747 [TBL] [Abstract][Full Text] [Related]
48. The role of aldosterone receptor antagonists in the management of heart failure: an update. Nagarajan V; Chamsi-Pasha M; Tang WH Cleve Clin J Med; 2012 Sep; 79(9):631-9. PubMed ID: 22949344 [TBL] [Abstract][Full Text] [Related]
49. Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee. Butler J; Ezekowitz JA; Collins SP; Givertz MM; Teerlink JR; Walsh MN; Albert NM; Westlake Canary CA; Carson PE; Colvin-Adams M; Fang JC; Hernandez AF; Hershberger RE; Katz SD; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Stough WG; Starling RC J Card Fail; 2012 Apr; 18(4):265-81. PubMed ID: 22464767 [TBL] [Abstract][Full Text] [Related]
50. [Aldosterone receptor antagonists in heart failure. Rightly brought back from retirement]. Kolloch R; Offers E MMW Fortschr Med; 2003 Nov; 145(47):42-4, 47. PubMed ID: 14725033 [TBL] [Abstract][Full Text] [Related]
51. Should the aldosterone-receptor antagonist - eplerenone - be used after acute myocardial infarction with left ventricular dysfunction? Doggrell S Expert Opin Pharmacother; 2003 Sep; 4(9):1605-7. PubMed ID: 12943490 [No Abstract] [Full Text] [Related]
52. Aldosterone antagonists in hypertension and heart failure. Mantero F; Lucarelli G Ann Endocrinol (Paris); 2000 Feb; 61(1):52-60. PubMed ID: 10790593 [TBL] [Abstract][Full Text] [Related]
53. Integrating traditional and emerging treatment options in heart failure. Nolan PE Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S14-22. PubMed ID: 15160834 [TBL] [Abstract][Full Text] [Related]
54. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers. Aaronson K Health News; 2003 May; 9(5):4. PubMed ID: 12739453 [No Abstract] [Full Text] [Related]
55. Aldosterone antagonism and myocardial infarction: from animals to man and back. Solomon SD; Pfeffer MA J Am Coll Cardiol; 2003 Nov; 42(9):1674-6. PubMed ID: 14607458 [No Abstract] [Full Text] [Related]
56. Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS. Zhang Z; Mahoney EM; Kolm P; Spertus J; Caro J; Willke R; Weintraub WS Am J Cardiovasc Drugs; 2010; 10(1):55-63. PubMed ID: 20104935 [TBL] [Abstract][Full Text] [Related]
57. Management of heart failure and left ventricular systolic dysfunction following acute myocardial infarction. Conti CR Clin Cardiol; 2005 Jan; 28(1):1-2. PubMed ID: 15704523 [No Abstract] [Full Text] [Related]
58. [Mineralocorticoid receptor antagonist spironolactone improves left ventricular remodeling in patients with congestive heart failure and acute myocardial infarction]. Tsutamoto T Nihon Yakurigaku Zasshi; 2004 Aug; 124(2):90-100. PubMed ID: 15277727 [TBL] [Abstract][Full Text] [Related]
59. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study. Iraqi W; Rossignol P; Angioi M; Fay R; Nuée J; Ketelslegers JM; Vincent J; Pitt B; Zannad F Circulation; 2009 May; 119(18):2471-9. PubMed ID: 19398668 [TBL] [Abstract][Full Text] [Related]
60. Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension. White WB; Carr AA; Krause S; Jordan R; Roniker B; Oigman W Am J Cardiol; 2003 Jul; 92(1):38-42. PubMed ID: 12842242 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]